Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study

Lulu Bravo National Institutes of Health-University of The Philippines Manila; Manila, The PhilippinesCorrespondence[email protected]

Amarjeet Chitraka Max Superspeciality Hospital; Shalimar bagh; Delhi, India

Aixue Liu GlaxoSmithKline Vaccines; King of Prussia, PA USA

Jaydeep Choudhury Dr Jaydeep’s Clinic; Kolkata, India

Kishore Kumar The Cradle; Bangalore, India

Lennie Berezo West Visayas State University Medical Center; Jaro, Iloilo City, The Philippines

Leonard Cimafranca Chong Hua Hospital; Cebu City, The Philippines

Pallab Chatterjee Salt Lake Medical Center; Kolkata, India

Pankaj Garg DNB Pediatrics; Consultant; Department of Neonatology; Sir Ganga Ram Hospital; New Delhi, India

Prasanna Siriwardene Family Clinic; Piliyandala; Colombo, Sri Lanka

Rommel Bernardo Davavo Doctors Hospital; Davao City, The Philippines

Shailesh Mehta GlaxoSmithKline Pharmaceuticals Pvt. Ltd.; India

Sundaram Balasubramanian Kanchi Kamakoti Trust Hospital; Chennai, India

Naveen Karkada GlaxoSmithKline Pharmaceuticals Pvt. Ltd.; India

Htay Htay Han GlaxoSmithKline Vaccines; King of Prussia, PA USA

Your download is now in progress and you may close this window